Capricor Therapeutics earnings were -$40.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CAPR earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$7.1M, down 43.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CAPR reported annual earnings of -$40.5M, with 81.6% growth. The next CAPR earnings date is May 12, 2025.
Capricor Therapeutics Earnings Reports & History FAQ
What were Capricor Therapeutics's earnings last quarter?
On CAPR's earnings call on Invalid Date, Capricor Therapeutics (NASDAQ: CAPR) reported Q4 2024 earnings per share (EPS) of -$0.11, up 650% year over year. Total CAPR earnings for the quarter were -$7.12 million. In the same quarter last year, Capricor Therapeutics's earnings per share (EPS) was $0.02.
The next CAPR earnings date is Invalid Date. Add CAPR to your watchlist to be reminded of Capricor Therapeutics's next earnings date.
What was CAPR's earnings growth in the past year?
As of Capricor Therapeutics's earnings date in Invalid Date, Capricor Therapeutics's earnings has grown year over year. CAPR earnings in the past year totalled -$40.47 million.
Is Capricor Therapeutics profitable or losing money?
As of the last Capricor Therapeutics earnings report, Capricor Therapeutics is currently losing money. Capricor Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$40.47 million, a 81.57% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.